The Family Smoking Prevention and Tobacco Control Act directed the FDA's Tobacco Products Scientific Advisory Committee to provide a report and recommendation on the impact of menthol cigarettes on public health. The committee submitted its report to the FDA in March 2011.
We actively participated in the TPSAC hearings and filed comments to FDA's dockets. We shared our perspective on the science and evidence relating to menthol, including our view that menthol cigarettes are not more toxic than non-menthol cigarettes, and that menthol does not play a unique role in smoking prevalence, dependence or cessation. Review our TPSAC presentations and comments.
In 2013, the FDA published an Advance Notice of Proposed Rulemaking seeking information from the public regarding potential regulation of menthol in cigarettes. With this notice, the FDA also released its independent review of the science related to menthol in cigarettes. This included an external peer review of the FDA’s assessment of the science.
Then, in 2018, FDA published an Advance Notice of Proposed Rulemaking on flavors in tobacco products, including menthol in cigarettes.